EONE continues its efforts to serve as a leader
of the medical science of the future
| Test Code | Test item | Specimen | Test Schedule | analytic time |
|---|---|---|---|---|
| A6629 | TGFBI mutation (Sequencing) | WB(EDTA) | Mon-Fri | 3 days |
| D6999 | TGFBI R124H Avellino corneal dystrophy (PCR) | Buccal swab | Mon-Sat | 1 day |
| D6999 | TGFBI R124H Avellino corneal dystrophy (PCR) | WB(EDTA) | Mon-Sat | 1 day |
| H0766 | TGFBR1 gene, mutation (Loeys-Dietz syndrome) | WB(EDTA) | Mon-Thu | 5 weeks |
| H0767 | TGFBR2 gene, mutation (Loeys-Dietz syndrome) | WB(EDTA) | Mon-Thu | 5 weeks |
| B5352 | Theophylline | Serum | Mon-Sat | 1 day |
| H0678 | THRB gene (Des)[Sequencing] | WB(EDTA) | Mon-Thu | 3 weeks |
| A0530 | Thrombin AT-III Com. | Sod. Citrate | Tue,Fri | 15 days |
| B1560 | Thrombin time | Sod. Citrate | Mon,Wed,Fri | 1 day |
| IHC2005 | Thyroid papillary carcinoma | Paraffin Block | Mon-Fri | 3 days |
| A0718 | Thyroid stimulating Ab | Serum | Mon,Wed,Fri | 2 days |
| B2870 | TIBC | Serum | Mon-Sat(Night) | 1 day |
| A6554 | Tissue Mineral Analysis | TMA | Mon-Thu | 10 days |
| C6817 | TKI (major BCR/ABL1) [Sequencing] | WB(EDTA) | Mon-Thu | 12 days |
| C6817 | TKI (major BCR/ABL1) [Sequencing] | Bone marrow | Mon-Thu | 12 days |
| C6048 | TLX3 (5q35) | Bone marrow | Mon-Thu | 2 weeks |
| C6048 | TLX3 (5q35) | Cell pellet | Mon-Thu | 2 weeks |
| C6048 | TLX3 (5q35) | other | Mon-Thu | 2 weeks |
| D1668 | TM (TPO)-Ab | Serum | Mon-Sat(Night) | 1 day |
| C3760 | TMAO (Trimethylamine N-oxide) | Serum | Fri | 3 days |